Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation

被引:18
作者
Bubnic, SJ
Keating, A
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Toronto Gen Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
关键词
D O I
10.1016/S0301-472X(02)00800-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To study the homing of donor stem cells, their contribution to short- and long-term hematopoiesis, and their functional capacity in an unconditioned marrow transplant model using a clinically relevant low marrow cell dose. Materials and Methods. A sex-mismatch model was used in which 20 x 10(6) male Balb/cByJ cells were infused into unconditioned female Balb/cByJ mice. Male donor cells were detected in blood and marrow by fluorescence in situ hybridization. Serial transplantation into irradiated secondary recipients was used to assay donor stem cells. Donor hematopoiesis was stimulated after transplant by treating recipients with either stem cell factor (SCF) or sublethal irradiation. Results. Donor-derived male cells were detected in recipient blood (1.2-3.0%) and marrow (2.4-5.4%) for up to 27 weeks, indicating a contribution to short-term hematopoiesis. Male repopulating units approached theoretically expected values, suggesting that transplantation was efficient. Donor stem cell levels after serial transplantation were similar to results observed in primary recipients. Donor stem cell levels 24 hours after infusion (1.3 +/- 0.2% SE) were similar to levels at later time points, indicating that homing was efficient. Stimulation by either SCF or sublethal irradiation after transplant did not alter donor marrow chimerism, suggesting that donor stem cells responded to the stress similarly to endogenous cells, Conclusion. We conclude that in a clinically relevant low-cell-dose unconditioned transplant model, stem cells home to the marrow efficiently, contribute to both short- and long-term hematopoiesis, and, once engrafted, respond to stress effectively. These findings provide a rationale for the use of genetically modified stem cells in clinical protocols that omit intensive conditioning. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 26 条
[1]   SPECIAL PROLIFERATIVE SITES ARE NOT NEEDED FOR SEEDING AND PROLIFERATION OF TRANSFUSED BONE-MARROW CELLS IN NORMAL SYNGENEIC MICE [J].
BRECHER, G ;
ANSELL, JD ;
MICKLEM, HS ;
TJIO, JH ;
CRONKITE, EP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (16) :5085-5087
[2]  
BRECHER G, 1979, BLOOD CELLS, V5, P237
[3]  
BUCKLEY RH, 1993, SEMIN HEMATOL, V30, P92
[4]  
COGGLE JE, 1975, EXP HEMATOL, V3, P181
[5]   NON-H-2 AND H-2-LINKED IMMUNE-RESPONSE GENES CONTROL THE CYTO-TOXIC T-CELL RESPONSE TO H-Y [J].
FIERZ, W ;
BRENAN, M ;
MULLBACHER, A ;
SIMPSON, E .
IMMUNOGENETICS, 1982, 15 (03) :261-270
[6]   STEEL FACTOR INFLUENCES THE DISTRIBUTION AND ACTIVITY OF MURINE HEMATOPOIETIC STEM-CELLS INVIVO [J].
FLEMING, WH ;
ALPERN, EJ ;
UCHIDA, N ;
IKUTA, K ;
WEISSMAN, IL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3760-3764
[7]   Hematopoietic stem cells [J].
Gunsilius, E ;
Gastl, G ;
Petzer, AL .
BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (04) :186-194
[8]  
HARRISON DE, 1993, BLOOD, V81, P2473
[9]  
HARRISON DE, 1993, EXP HEMATOL, V21, P206
[10]  
Hendrikx PJ, 1996, EXP HEMATOL, V24, P129